EventEvolution of IL-23 inhibitors for Crohn’s disease management
9 Mar 2022 - 9 Mar 2022
SpeakerSilvio Danese, Italy - Laurent Peyrin-Biroulet, France - Subrata Ghosh, Ireland - Peter Irving, UK
Download the program
The evolution of biological drugs has made major steps forwards for the treatment of IBD. Among these biologicals are the IL-23 inhibitors for which new agents as well as new data on monoclonal antibodies are becoming available for the treatment of CD.